Table 4.
Online survey results
Online survey | Percentage |
---|---|
The survey showed that ~30% of COPD patients did not follow the therapy suggested by GOLD. Why? | |
Guidelines far from reality | 60 |
Guidelines are difficult to apply | 20 |
Poor knowledge of the guidelines | 20 |
Why “ABCD” model is difficult to routinely use? | |
Spirometry is not always feasible | 40 |
mMRC or CAT not always feasible | 20 |
Increased visit time | 30 |
Others | 10 |
Most discrepancies are related to the excessive use of ICS. How do you explain it? | |
Information received from pharmaceutical companies | 50 |
The corticosteroids are more effective | 30 |
Others | 20 |
Higher percentages of patients are inappropriately treated by triple therapy. Why? | |
Guarantees better and faster results on the patient’s symptoms | 35 |
Easier to prescribe than double bronchodilation | 40 |
Business issues | 15 |
Others | 10 |
Approximately 11% of patients in Group D did not take any therapy at the time of their first visit. | |
What are the causes? | |
The general medical practitioner underestimates the disease | 45 |
Patients underestimate the disease | 40 |
Both | 15 |
Abbreviations: CAT, COPD Assessment Test; GOLD, Global initiative for chronic Obstructive Lung Disease; ICS, inhaled corticosteroids, mMRC, Modified Medical Research Council.